| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/07/1998 | US5736149 Allergenic proteins and peptides from johnson grass pollen |
| 04/07/1998 | US5736143 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/07/1998 | US5736142 Alteration of immune response using pan DR-binding peptides |
| 04/07/1998 | US5736139 Treatment of Clostridium difficile induced disease |
| 04/07/1998 | US5736138 Antagonist |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/07/1998 | US5736136 Immunoglobulin infusion in xenotransplantation |
| 04/07/1998 | US5736135 Method for making variant secreted proteins with altered properties |
| 04/07/1998 | US5736134 Tissue plasminogen activator variants |
| 04/07/1998 | US5736133 Method and composition for the treatment of a individual infected with an immunodeficiency virus |
| 04/07/1998 | US5736132 Applying tissue transglutaminase to tissue to promote adhesion in presence of calcium or strontium ions at specified concentration and ph |
| 04/07/1998 | US5736119 Using a naturally-occuring protein that chelated metal ions and has a molecular weight of at least 60,000 daltons |
| 04/07/1998 | US5736010 Forming collagen and cellulose mixture into sheets |
| 04/07/1998 | CA2217409A1 Pharmaceutical preparations for intranasal administration |
| 04/07/1998 | CA2130116C Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/07/1998 | CA1339808C Glycopeptide antibiotics |
| 04/07/1998 | CA1339801C Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 04/07/1998 | CA1339798C Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans |
| 04/02/1998 | WO1998013509A1 Novel morphogen-responsive signal transducer and methods of use thereof |
| 04/02/1998 | WO1998013496A1 Chaperone fragments |
| 04/02/1998 | WO1998013495A1 Human rantes mutants incapable of aggregate formation |
| 04/02/1998 | WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/02/1998 | WO1998013492A2 Isolation and use of motoneuronotrophic factors |
| 04/02/1998 | WO1998013489A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | WO1998013488A2 Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease |
| 04/02/1998 | WO1998013487A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | WO1998013485A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | WO1998013484A1 Two human cathepsin proteins |
| 04/02/1998 | WO1998013475A1 Methods for culturing cells |
| 04/02/1998 | WO1998013388A1 Antibody against human parathormone related peptides |
| 04/02/1998 | WO1998013386A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | WO1998013385A2 Non-naturally occurring lipoprotein particle |
| 04/02/1998 | WO1998013384A1 Insulin c-peptides |
| 04/02/1998 | WO1998013383A1 Adenoviral vectors for mutants of human interleukin 6 (hil-6) with hil-6 antagonist activity, pharmaceutical compositions therewith and their uses |
| 04/02/1998 | WO1998013382A1 A process for culturing cells |
| 04/02/1998 | WO1998013381A1 Modified physiologically active proteins and medicinal compositions containing the same |
| 04/02/1998 | WO1998013380A1 Snrnp sm proteins |
| 04/02/1998 | WO1998013379A1 METHOD OF CELL INHIBITION USING POLYPEPTIDES DERIVED FROM THE VENOM OF THE AUSTRIALIAN JUMPER ANT $i(MYRMECIA PILOSULA) |
| 04/02/1998 | WO1998013377A1 Cytotoxic peptides |
| 04/02/1998 | WO1998013376A1 Inhibitors of pla¿2? |
| 04/02/1998 | WO1998013375A1 Compounds with antimycotic and cytostatic effect, preparation method, agent containing these compounds and dsm 11 092 |
| 04/02/1998 | WO1998013374A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | WO1998013072A1 Compositions for and methods of treating multiple drug resistance |
| 04/02/1998 | WO1998013071A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | WO1998013070A1 Non-invasive administration of adeno-associated viral vectors |
| 04/02/1998 | WO1998013067A1 Method of preventing acute rejection following solid organ transplantation |
| 04/02/1998 | WO1998013066A1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 04/02/1998 | WO1998013064A1 Factors which interact with oncoproteins |
| 04/02/1998 | WO1998013063A1 Cyclic peptide antitumor agent from an ascidian |
| 04/02/1998 | WO1998013062A1 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression |
| 04/02/1998 | WO1998013061A1 Inhibition of 26s and 20s proteasome by indanones |
| 04/02/1998 | WO1998013060A1 Use of a cytokine regulatory agent to treat rheumatoid arthritis |
| 04/02/1998 | WO1998013059A1 Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| 04/02/1998 | WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 04/02/1998 | WO1998013046A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals |
| 04/02/1998 | WO1998013044A1 Pharmaceutical compositions and methods of treating compulsive disorders using naaladase inhibitors |
| 04/02/1998 | WO1998013032A1 Compositions of therapeutic agents suitable for oral administration |
| 04/02/1998 | WO1998013029A1 Oral delayed immediate release formulation and method of preparation therefor |
| 04/02/1998 | WO1998013024A2 Hyaluronic drug delivery system |
| 04/02/1998 | WO1998013007A2 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | WO1998012910A2 NOVEL CREBa ISOFORM |
| 04/02/1998 | WO1998007878A3 Long-term expression of gene products by transforming muscle cells |
| 04/02/1998 | WO1998002454A3 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 04/02/1998 | DE19643764A1 Glycokonjugate von modifizierten Camptothecin-Derivaten (20-0-Verknüpfung) Glycoconjugates of modified camptothecin derivatives (20-0 link) |
| 04/02/1998 | DE19641518A1 Mistletoe chitin-binding lectin |
| 04/02/1998 | DE19640555A1 Use of isoxazole-amide or croton-amide derivatives to modulate apoptosis |
| 04/02/1998 | DE19640207A1 Glycokonjugate von modifizierten Camptothecin-Derivaten (A- oder B-Ring-Verknüpfung) Glycoconjugates of modified camptothecin derivatives (A or B ring junction) |
| 04/02/1998 | DE19632404A1 Artificial tissue comprising three-dimensional extracellular matrix, cell interaction system |
| 04/02/1998 | CA2268265A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | CA2267666A1 Novel morphogen-responsive signal transducer and methods of use thereof |
| 04/02/1998 | CA2267332A1 Methods for culturing cells |
| 04/02/1998 | CA2267179A1 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2266746A1 Inhibitors of pla2 |
| 04/02/1998 | CA2266744A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | CA2266619A1 Non-invasive administration of adeno-associated viral vectors |
| 04/02/1998 | CA2266427A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | CA2266423A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | CA2266419A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | CA2266336A1 Method of cell inhibition using polypeptides derived from the venom of the austrialian jumper ant myrmecia pilosula |
| 04/02/1998 | CA2266329A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | CA2266315A1 Method of preventing acute rejection following solid organ transplantation |
| 04/02/1998 | CA2266098A1 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression |
| 04/02/1998 | CA2264546A1 Two human cathepsin proteins |
| 04/02/1998 | CA2264544A1 Snrnp sm proteins |
| 04/02/1998 | CA2264227A1 Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| 04/02/1998 | CA2264158A1 Pharmaceutical compositions and methods of treating compulsive disorders using naaladase inhibitors |
| 04/02/1998 | CA2264043A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals |
| 04/02/1998 | CA2263134A1 Cytotoxic peptides |
| 04/02/1998 | CA2236154A1 Novel creba isoform |
| 04/02/1998 | CA2213257A1 Oligopeptide derivatives |
| 04/01/1998 | EP0832978A2 Novel 3-dehydroquinate synthase |
| 04/01/1998 | EP0832977A2 Novel sugar kinase |
| 04/01/1998 | EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus |
| 04/01/1998 | EP0832973A2 GTP-binding protein |
| 04/01/1998 | EP0832971A1 Adheson variants |
| 04/01/1998 | EP0832900A1 Peptide and method of obtaining it |
| 04/01/1998 | EP0832879A1 Process for preparing intermediates for thrombin inhibitors |
| 04/01/1998 | EP0832653A1 Use of cytokines and cytotoxic compounds in a method for treatment of tumours |
| 04/01/1998 | EP0832289A1 Novel gene-up regulated in regenerating liver |
| 04/01/1998 | EP0832282A1 IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES |